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Abstract
Background: In adults, the TCF7L2 rs7903146 T allele, commonly associated with type 2 diabetes
(T2D), has been also associated with a lower body mass index (BMI) in T2D individuals and with a
smaller waist circumference in subjects with impaired glucose tolerance.
Methods: The present association study aimed at analyzing the contribution of the rs7903146 SNP
to smallness for gestational age (SGA) and metabolic profiles in subjects with SGA or appropriate
for gestational age birth weight (AGA). Two groups of French Caucasian subjects were selected on
birth data: SGA (birth weight < 10th percentile; n = 764), and AGA (25th < birth weight < 75th
percentile; n = 627). Family-based association tests were also performed in 3,012 subjects from 628
SGA and AGA pedigrees.
Results: The rs7903146 genotypic distributions between AGA (30.7%) and SGA (29.0%) were not
statistically different (allelic OR = 0.92 [0.78–1.09], p = 0.34). Family association-based studies did
not show a distortion of T allele transmission in SGA subjects (p = 0.52). No significant effect of
the T allele was detected on any of the metabolic parameters in the SGA group. However, in the
AGA group, trends towards a lower insulin secretion (p = 0.03) and a higher fasting glycaemia (p
= 0.002) were detected in carriers of the T allele.
Conclusion: The TCF7L2 rs7903146 variant neither increases the risk for SGA nor modulates
birth weight and young adulthood glucose homeostasis in French Caucasian subjects born with
SGA.
Background
Evidence has accumulated that smallness for gestational
age (SGA) children have long-term adult health conse-
quences including obesity, type 2 diabetes (T2D), hyper-
tension, coronary artery disease and stroke [1]. This
increased risk of later adult disease is likely to be, at least
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in part, a consequence of an early and persistent insulin
resistance although other mechanisms affecting beta-cell
function are not excluded [2,3]. In non-pathological con-
ditions, the fetal growth results from complex interactions
of maternal and fetal genes with environmental factors
such as maternal nutrition and smoking and placental
function. Evidence for a genetic contribution for SGA has
been reported [4,5] but few genes, associated with diabe-
tes have been reported to also influence birth weight (BW)
such as the INS VNTR locus [6-8] and the GCK gene [9-
12]. The TCF7L2 rs7903146 polymorphism has been con-
sistently associated with T2D and is probably the causa-
tive ancestral allele [13]. In adults, this SNP has been also
associated with a lower body mass index (BMI) in T2D
individuals [14] as well as with a smaller waist circumfer-
ence in subjects with impaired glucose tolerance [15].
As O'Rahilly et al. recently suggested that the study of
TCF7L2 should require the analysis of cohorts ascertained
for insulin resistance [16], we investigated the relative
contribution of the rs7903146 T allele to SGA by compar-
ing 764 individuals with an appropriate for gestational
age (AGA) BW (25th < BW < 75th percentile) and 627 SGA
subjects (BW < 10th percentile.). Because the mother's gen-
otype may also influence fetal growth, mother-child pairs
(n = 361 for SGA and n = 215 for AGA) were also studied.
Family-based association tests were then performed in
3,012 subjects from 628 SGA and AGA pedigrees. Birth
weight was also analyzed in 845 obese children (BMI =
97th percentile), prone to macrosomia at birth and geno-
typed for the rs7903146 variant. Finally, we tested the
effects of the T allele on birth and adult metabolic param-
eters in SGA and AGA individuals.
Methods
Haguenau case/control cohort
French Caucasian subjects born between 1971 and 1985
were identified from a population-based registry encom-
passing more than 20,000 births in the metropolitan area
of the city of Haguenau, France. Only singletons were
included. Gestational age was determined from the date
of the mother's last menstrual period and by physical
examination during pregnancy, confirmed by ultrasound
measurements when available (> 80%). Case-control
association tests were performed on two unrelated groups,
selected on birth data derived from the local reference
curves drawn for gender and gestational age: SGA (birth
weight < 10th percentile; n = 627 subjects; 294 men and
333 women) and AGA (birth weight between 25th and
75th percentile; n = 764 subjects; 369 men and 395
women).
Familial association tests were performed on 3,012 indi-
viduals from 628 pedigrees, among which 744 children
with SGA, and 1,128 children with AGA. All individuals
from the case-control study were included in the familial
study.
Birth parameters, consisting of birth weight, length, and
ponderal index, were collected from the registry. At a
mean age of 22 yr, all subjects underwent a medical exam-
ination to assess anthropometric parameters (weight,
height, waist to hip ratio). We assessed the pancreatic
beta-cell function by HOMA beta-cell (HOMA-B) index,
as the product of the fasting plasma insulin level (μU/ml)
and 20, divided by the fasting plasma glucose level
(mmol/l) minus 3.5. To estimate insulin resistance,
HOMA-IR was calculated as the product of the fasting
plasma insulin level (μU/ml) and the fasting plasma glu-
cose level (mmol/l), divided by 22.5. Fasting insulin,
HOMA-B and HOMA-IR were then converted into natural
logarithm (Ln) value to normalize the distribution. Total
cholesterol, high-density lipoprotein (HDL)-cholesterol,
and triglyceride concentrations were measured fasting.
The study protocol was reviewed and approved by the fac-
ulty ethics committee, and all subjects and parents gave
signed written consent.
Obese children cohort
All individuals were French Caucasians and were recruited
using a multimedia campaign run by the "Centre National
de la Recherche Scientifique" (CNRS), UMR8090. All sub-
jects were obese children (n = 845, sex ratio (m/w) = 407/
438, age = 11 ± 3 years, BMI z-score = 6.1 ± 2.9, birth
weight = 3,448 ± 549 g). The study protocol was approved
by the local ethic committee and an informed consent was
obtained from each subject before participating in the
study.
Genotyping methods
High-throughput genotyping of the s7903146 variant was
performed using the TaqMan® SNP Genotyping Assays
(Applied Biosystems, Foster City, Calif. USA). The PCR
primers and TaqMan probes were designed by Primer
Express and optimized according to the manufacturer's
protocol. There was a 98% genotyping success rate and the
genotyping error rate was assessed by sequencing 384 con-
trol and 384 T2D individuals and by re-genotyping a ran-
dom 10% sample. No difference was found with the first
genotyping results, thus the genotyping error rate was 0%.
Statistical methods
Tests for deviation from Hardy-Weinberg equilibrium
(HWE) and for association were performed with the De
Finetti program [17]. Considering that the model of
inheritance of the rs7903146 T allele has been found to be
additive in the French population [14], we only analyzed
allelic odds ratios. Given a 30% allelic frequency for the
rs7903146 T allele and a frequency of 10% of SGA, theBMC Medical Genetics 2007, 8:37 http://www.biomedcentral.com/1471-2350/8/37
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power of the case-control and family studies was then >
75% to observe an odds ratio = 1.2. Family-based associ-
ation tests were performed by TDT methods implemented
in the FBAT software. For the mother-child pairs, the effect
of the T allele on birth weight was tested by linear regres-
sion model adjusted for the child's gender and gestational
age. For that analysis, the power was > 80% to observe a
birth weight variation of 80 g and 60 g in the AGA and
SGA groups, respectively. A Student's T-test was applied to
compare quantitative traits between SGA and AGA, with-
out taking into account the rs7903146 genotype. Quanti-
tative traits were then measured by linear regression
models. These models took known covariables into
account: gender and gestational age when testing for birth
weight, birth length and ponderal index; age at examina-
tion and gender when testing for adult weight, adult
height, body mass index (BMI), and waist to hip ratio; age
at examination, gender, BMI, when testing for total
plasma cholesterol, HDL, triglyceride, fasting glucose,
fasting insulin, HOMA-B, HOMA-IR. The power was 80%
to observe a variation in fasting glucose concentration of
0.01 g/l and to observe a variation in Ln(HOMA-B) of
0.09 units in the SGA and AGA groups. All tests were two-
tailed, and p < 0.05 was considered to be statistically sig-
nificant. No Bonferroni corrections were applied due to
insufficient power. All p values were two-tailed. SPSS 14.1
software (SPSS Inc., Chicago, IL, USA) was used for gen-
eral statistical analyses.
Results
Association studies
Comparison of the rs7903146 T allele frequencies in AGA
(30.7%; 368 C/C, 323 C/T and 73 T/T) and SGA (29.0%;
319 C/C, 252 C/T and 56 T/T) are presented in Figure 1.
The genotypic distributions between the two groups were
in Hardy-Weinberg equilibrium (p = 0.86 for AGA and p=
0.56 for SGA) but were not statistically different (allelic
OR = 0.92 [0.78–1.09], p = 0.34). Then the respective
effects of mother's and child's genotypes on birth weight
were tested by linear regression models (Table 2). No dif-
ferences in birth weight were found within the 361
mother-child pairs of the SGA group (p = 0.93) and
within the 215 mother-child pairs of the AGA group (p=
0.59). Family association-based studies did not show a
distortion of T allele transmission in SGA subjects (48.5%
for the T allele vs 51.5% for the C allele, p = 0.52). In 845
obese children (BMI = 97th percentile), we tested the con-
tribution to BW of the rs7903146 genotype by linear
regression and after adjustments for gestational age and
gender. In this sample, 404 children were C/C (BW =
3,466 ± 506 g), 356 were C/T (BW = 3,425 ± 567 g) and
85 were T/T (BW = 3,464 ± 668 g). The genotypic distribu-
tion was in Hardy-Weinberg equilibrium and no differ-
ence was found between the 3 genotypic groups (p = 0.61)
Quantitative trait analysis
We first analyzed birth and adult (at around 22 years of
age) metabolic parameters in AGA and SGA, without tak-
ing into account the rs7903146 genotype (Table 1). Insu-
lin resistance (assessed by HOMA-IR index) and lipids
profile were significantly different between SGA and AGA
individuals. Then, we analyzed the effect of the rs7903146
T allele on quantitative traits by birth status and by geno-
type (Table 1). No significant effect was detected on any
of the metabolic parameters in the SGA group. In the AGA
group, however, trends towards a lower Ln(HOMA-B) and
towards a higher fasting glucose were detected within the
carriers of the T allele. No interaction between the birth
status (AGA/SGA) and the rs7903146 variant was found
in any of the quantitative traits. The absence of interaction
between the genotype and the birth status for fasting glu-
cose and Ln(HOMA-B) may be due to a lack of power.
Discussion
We found no association between the rs7903146 T allele
and SGA, either by case-control or family-based associa-
tion studies. This may be not surprising as the main quan-
titative phenotypic effect previously associated with the T
allele, at risk for T2D, was only a modest decrease of insu-
TCF7L2 rs7903146 T allele does not associate with SGA Figure 1
TCF7L2 rs7903146 T allele does not associate with 
SGA. The T allele frequencies were not significantly different 
between the SGA and AGA groups (Allelic OR = 0.92 [0.78–
1.09], P = 0.34). SGA: Smallness for Gestational Age. AGA: 
Appropriate for Gestational Age birth weight.
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lin secretion [14,15,18]. Fetal circulating insulin levels
positively correlate with birth weight [19], and therefore,
any impaired fetal insulin secretion may only lead to a
small decrease in birth weight and not to the more severe
SGA condition. Maternal fasting glucose concentration
during pregnancy, is also an important determinant of
offspring birth weight by stimulating the release of fetal
insulin [20]. However, we found no effect of mother's
genotype on offspring's birth weight, neither by itself nor
by interaction with child's genotype. The lack of associa-
tion of TCF7L2 variation with birth weight was also sup-
ported by the analysis of another cohort of French
children ascertained by further development of early
onset obesity. Interestingly, trends towards a lower insulin
secretion and a higher fasting glycaemia were detected in
young AGA adults carrying the rs7903146 T allele, in
accordance with previous data [14,15,18]. However, the
observation of young SGA adults revealed no significant
effect of T allele on glucose homeostasis, suggesting that
insulin resistance may influence some consequences of
this genetic variant, as recently suggested by Watanabe et
al. [21]. Further studies remain necessary in other ethnic
Table 1: Effects of the TCF7L2 rs7903146 T allele on birth and adult parameters in SGA and AGA individuals
Quantitativ
e traits
AGA SGA T-test AGA by genotype LR SGA by genotype LR Interaction
n = 764 n = 627 p value C/C C/T T/T p value C/C C/T T/T p value p value
aBirth 
weight (g)
3366 ± 
267
2614 ± 
303
8 × 10-306 3364 ± 
268
3376 ± 
260
3334 ± 
294
0.78 2623 ± 
306
2601 ± 
309
2622 ± 
258
0.64 0.77
aBirth 
length (cm)
50.35 ± 
1.2
47.68 ± 
2.1
2 × 10-152 50.3 ± 
1.21
50.4 ± 1.1 50.3 ± 1.2 0.61 47.8 ± 2.2 47.6 ± 2.0 47.7 ± 2.0 0.80 0.68
aPonderal 
index 
(kg/m3)
26.36 ± 
1.6
24.19 ± 
2.3
5 × 10-79 26.4 ± 1.7 26.3 ± 1.6 26.17 ± 
1.6
0.41 24.2 ± 2.3 24.2 ± 2.4 24.1 ± 2.5 0.84 0.80
BMI (kg/
m2)
22.72 ± 
3.97
22.51 ± 
4.33
0.36 22.7 ± 3.7 227 ± 4.1 22.7 ± 4.5 0.90 22.9 ± 4.5 22.0 ± 3.9 22.6 ± 5 0.66 0.81
Waist to 
hip ratio 
(no unit)
0.8 ± 0.08 0.81 ± 
0.08
0.20 0.8 ± 0.1 0.81 ± 0.1 0.79 ± 0.1 0.43 0.8 ± 0.1 0.8 ± 0.1 0.8 ± 0.1 0.83 0.86
HDL 
cholesterol 
(mmol/l)
1.43 ± 
0.35
1.4 ± 0.36 0.06 1.4 ± 0.3 1.4 ± 0.3 1.5 ± 0.4 0.32 1.4 ± 0.4 1.4 ± 0.3 1.4 ± 0.3 0.68 0.76
Triglycerid
emia 
(mmol/l)
1.03 ± 
0.53
1.1 ± 0.59 0.01 1.0 ± 0.51 1.09 ± 
0.55
0.88 ± 
0.49
0.33 1.14 ± 
0.64
1.04 ± 0.5 1.2 ± 0.61 0.34 0.21
Fasting 
glucose (g/l)
0.86 ± 
0.06
0.87 ± 
0.07
0.14 0.86 ± 
0.07
0.86 ± 
0.07
0.88 ± 
0.07
0.002 0.87 ± 
0.07
0.86 ± 
0.06
0.88 ± 
0.11
0.64 0.13
Ln [Fasting 
insulin 
(mU/l)]
1.46 ± 0.5 1.53 ± 
0.58
0.03 1.5 ± 0.5 1.5 ± 0.5 1.4 ± 0.6 0.42 1.6 ± 0.6 1.5 ± 0.5 1.5 ± 0.7 0.48 0.90
Ln [HOMA-
B (no unit)]
4.24 ± 
0.56
4.29 ± 0.6 0.12 4.27 ± 
0.55
4.23 ± 
0.56
4.13 ± 
0.61
0.03 4.32 ± 
0.64
4.26 ± 
0.53
4.23 ± 
0.67
0.71 0.27
Ln [HOMA-
IR (no 
unit)]
-0.09 ± 
0.51
-0.02 ± 
0.61
0.02 -0.08 ± 
0.52
-0.10 ± 
0.49
-0.10 ± 
0.58
0.73 0.02 ± 
0.66
-0.05 ± 
0.52
-0.07 ± 
0.71
0.52 0.74
SGA: Small Gestational Age
AGA: Appropriate for Gestational Age birth weight
Insul. Index: Insulogenic index
a: Birth parameters
T-test: Student's T-test
LR: Linear regression models (every adjustments are presented in Subjects and Methods)
Birth status (AGA/SGA) × genotype interactions were presented on the right side of the table
Table 2: Birth weight parameters by mother and child rs7903146 genotypes
Mother-
child pairs
AGA by genotype LR SGA by genotype LR
C/C C/T T/T p value C/C C/T T/T p value
Mother 3371 ± 270 3366 ± 229 3447 ± 273 0.21a 2623 ± 325 2634 ± 294 2664 ± 238 0.76a
n 105 94 16 178 155 28
Child 3340 ± 255 3408 ± 246 3409 ± 264 0.59b 2644 ± 315 2600 ± 306 2695 ± 217 0.93b
n 108 87 20 193 140 28
n: Number of individuals
p value: the birth
LR: Linear regression model adjusted for child's gender and gestational age
a: Effect of the maternal genotype
b: Effect of the child genotype adjusted for the maternal genotypeBMC Medical Genetics 2007, 8:37 http://www.biomedcentral.com/1471-2350/8/37
Page 5 of 6
(page number not for citation purposes)
groups and in general populations in order to definitely
rule out any effect of TCF7L2  on birth weight.
Conclusion
In conclusion, we showed that the TCF7L2 rs7903146 var-
iant neither increases the risk for SGA nor modulates birth
weight and young adulthood glucose homeostasis in
French Caucasian subjects born with SGA.
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